Could Automation Rescue CAR-T Manufacturing?

 
• By Vibha Sharma

Manufacturing constraints have prevented even the most pioneering cell therapy companies from meeting patient demand for their life-saving treatments. They are still in the works, but could fully automated, closed manufacturing platforms be potential game changers?

Pipetting in the laboratory (with Manufacturing Focus logo)

The advent of cell therapies holds the promise of new cures and treatments, but the roll out of these high-cost medicines to eligible patients has been underwhelming to date.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business Strategy

More from In Vivo